Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alterity Therapeutics Limited has announced the cessation of 5 million options due to the non-fulfillment of conditional rights. These options, identified by the code ATHAAE and originally set to expire on November 29, 2026, officially ceased on May 7, 2024. This move is significant for investors tracking the company’s capital structure and stock performance.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.